ExploreWatchlistsPricing
  1. JP-listed companies
  2. Immuno-Biological Laboratories Co., Ltd.
  3. Financials
  4. Accounts payable

Immuno-Biological Laboratories Co., Ltd. (4570)

Market cap
¥14.1B
P/E ratio
53.1x
Develops antibody-based diagnostic tools and testing services for medical research, plus manufactures cosmetics using human-type collagen from silkworms.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndAccounts payable (Million JPY)YoY (%)
Mar 31, 20254-14.38%
Mar 31, 20244-23.73%
Mar 31, 20236+44.96%
Mar 31, 20224-45.78%
Mar 31, 20217+45.60%
Mar 31, 20205+4.06%
Mar 31, 20195-38.45%
Mar 31, 20188+441.60%
Mar 31, 20171-79.13%
Mar 31, 20167+40.40%
Mar 31, 20155

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat